Return to Home Incidence > Table

Incidence Rates Table

Data Options

Incidence Rate Report by State

Breast (Late Stage^), 2014-2018

All Races (includes Hispanic), Female, All Ages

Sorted by CI*Rank
State
 sort alphabetically by name ascending
Met Healthy People Objective of 42.1?
Age-Adjusted Incidence Rate
cases per 100,000
(95% Confidence Interval)
 sort by rate descending
CI*Rank⋔
(95% Confidence Interval)
 sort by CI rank descending
Average Annual Count
 sort by count descending
Percent of Cases with Late Stage
 sort by percent late descending
US (SEER+NPCR) 1 Yes 41.7 (41.6, 41.8) N/A 79,558 31.9
District of Columbia 6 No 50.5 (47.2, 54.1) 1 (1, 5) 180 35.9
Louisiana 3 No 46.9 (45.7, 48.1) 2 (1, 7) 1,284 36.0
Georgia 3 No 46.5 (45.7, 47.3) 3 (1, 6) 2,731 35.6
Mississippi 6 No 45.7 (44.3, 47.2) 4 (1, 15) 818 37.0
North Carolina 6 No 45.1 (44.4, 45.9) 5 (3, 13) 2,789 32.0
Illinois 6 No 45.0 (44.4, 45.8) 6 (3, 13) 3,423 33.0
Montana 6 No 44.8 (42.3, 47.3) 7 (1, 32) 281 31.3
Idaho 3 No 44.6 (42.6, 46.6) 8 (2, 29) 414 33.3
Maryland 6 No 44.4 (43.4, 45.4) 9 (4, 19) 1,626 32.9
South Carolina 6 No 44.4 (43.3, 45.5) 10 (4, 20) 1,374 32.9
Missouri 6 No 44.1 (43.1, 45.1) 11 (4, 21) 1,637 32.8
Ohio 6 No 44.0 (43.3, 44.7) 12 (6, 20) 3,185 32.8
Oklahoma 6 No 43.8 (42.6, 45.1) 13 (4, 26) 993 34.3
New Jersey 3 No 43.5 (42.7, 44.4) 14 (7, 23) 2,409 31.0
Pennsylvania 6 No 43.5 (42.9, 44.2) 15 (8, 22) 3,547 31.6
North Dakota 6 No 43.3 (40.3, 46.4) 16 (2, 44) 173 32.4
Wisconsin 6 No 42.9 (41.9, 43.9) 17 (9, 31) 1,489 31.1
Delaware 6 No 42.8 (40.4, 45.3) 18 (3, 43) 258 30.5
Kansas 6 No 42.5 (41.1, 44.0) 19 (7, 39) 705 31.3
New York 3 No 42.5 (41.9, 43.0) 20 (15, 29) 5,081 30.8
Iowa 3 No 42.4 (41.0, 43.9) 21 (8, 40) 784 30.7
New Hampshire 6 No 42.3 (40.3, 44.4) 22 (5, 43) 365 28.3
Alaska 6 No 42.3 (39.2, 45.6) 23 (2, 47) 150 34.5
Colorado 6 No 42.2 (41.1, 43.3) 24 (13, 37) 1,280 32.0
Kentucky 3 No 42.2 (41.0, 43.3) 25 (12, 38) 1,145 32.2
Nebraska 6 Yes 42.0 (40.3, 43.9) 26 (7, 43) 450 31.0
Washington 5 Yes 42.0 (41.1, 42.9) 27 (15, 37) 1,757 30.4
Utah 3 Yes 41.8 (40.3, 43.4) 28 (10, 43) 567 35.9
Virginia 6 Yes 41.7 (40.9, 42.5) 29 (17, 39) 2,072 32.0
Minnesota 6 Yes 41.4 (40.4, 42.5) 30 (17, 41) 1,314 29.7
California 3 Yes 41.2 (40.8, 41.6) 31 (24, 38) 8,964 33.1
Oregon 6 Yes 41.1 (40.0, 42.3) 32 (18, 43) 1,021 30.6
Florida 6 Yes 41.1 (40.6, 41.6) 33 (24, 40) 5,515 32.2
Connecticut 3 Yes 40.8 (39.5, 42.0) 34 (19, 44) 923 28.1
West Virginia 6 Yes 40.7 (39.0, 42.5) 35 (15, 45) 493 32.8
Tennessee 6 Yes 40.6 (39.7, 41.5) 36 (24, 43) 1,645 31.9
Hawaii 3 Yes 40.6 (38.6, 42.6) 37 (13, 47) 345 28.0
Indiana 6 Yes 40.6 (39.6, 41.5) 38 (24, 44) 1,594 31.7
Arkansas 6 Yes 40.5 (39.1, 41.8) 39 (19, 45) 732 32.8
Michigan 5 Yes 40.3 (39.5, 41.0) 40 (28, 44) 2,475 31.6
Alabama 6 Yes 39.7 (38.7, 40.8) 41 (29, 46) 1,209 31.9
Rhode Island 6 Yes 39.1 (36.9, 41.4) 42 (18, 49) 260 27.0
Wyoming 6 Yes 39.0 (35.9, 42.2) 43 (13, 50) 129 33.3
Maine 6 Yes 38.6 (36.7, 40.6) 44 (28, 49) 353 29.0
Nevada 6 Yes 38.2 (36.7, 39.8) 45 (35, 49) 503 32.4
Vermont 6 Yes 38.0 (35.2, 40.9) 46 (19, 50) 152 27.2
South Dakota 6 Yes 37.3 (34.8, 39.9) 47 (32, 50) 183 28.8
New Mexico 3 Yes 37.2 (35.6, 38.8) 48 (40, 50) 465 32.1
Texas 6 Yes 37.1 (36.7, 37.6) 49 (44, 49) 5,403 32.2
Arizona 6 Yes 35.1 (34.2, 35.9) 50 (48, 50) 1,432 29.5
Massachusetts 3 Yes
data not available
N/A
data not available
data not available
Puerto Rico 6 Yes 25.7 (24.7, 26.7) N/A 577 26.4
Notes:
Created by statecancerprofiles.cancer.gov on 05/20/2022 1:16 am.

State Cancer Registries may provide more current or more local data.

Data cannot be shown for the following areas. For more information on what areas are suppressed or not available, please refer to the table.
Massachusetts, Puerto Rico

⋔ Results presented with the CI*Rank statistics help show the usefulness of ranks. For example, ranks for relatively rare diseases or less populated areas may be essentially meaningless because of their large variability, but ranks for more common diseases in densely populated regions can be very useful. More information about methodology can be found on the CI*Rank website.

† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The 1969-2018 US Population Data File is used for SEER and NPCR incidence rates.

Rates are computed using cancers classified as malignant based on ICD-O-3. For more information see malignant.html.

^ Late Stage is defined as cases determined to be regional or distant. Due to changes in stage coding, Combined Summary Stage (2004+) is used for data from Surveillance, Epidemiology, and End Results (SEER) databases and Merged Summary Stage is used for data from National Program of Cancer Registries databases. Due to the increased complexity with staging, other staging variables maybe used if necessary.
Data not available for this combination of data selections.

Source: SEER and NPCR data. For more specific information please see the table.

Interpret Rankings provides insight into interpreting cancer incidence statistics. When the population size for a denominator is small, the rates may be unstable. A rate is unstable when a small change in the numerator (e.g., only one or two additional cases) has a dramatic effect on the calculated rate.

Data not available for this combination of geography, cancer site, age, and race/ethnicity.

Data for United States does not include Puerto Rico.
CI*Rank data for Puerto Rico is not available.

Return to Top